Is quality of care sacrificed with MCOs' financial incentives?

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.400, 2003-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Financial incentives: to pay or not to pay?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 552, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

What treatments are selected by physicians and MCOs?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 623, 2011-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Quality of care slipping?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 285, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Should Financial Incentives be Used to Differentially Reward `Me-Too' and Innovative Drugs?

By Pekarsky Brita

PharmacoEconomics, Vol. 28, Iss. 1, 2010-01 ,pp. : 1-17

Adis International

Access to resources Recommend Favorite

Incentives for malaria vaccine development?

Inpharma, Vol. 1, Iss. 1233, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite